This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Zygtech, LLC | 2,438,176 | 0 |
| Venrock Healthcare Capital Partners II, L.P. By Funds | 2,365,471 | 0 |
| Venrock Associates VI, L.P. By Funds | 2,365,471 | 0 |
| REGENERON PHARMACEUTICALS INC | 1,809,098 | 0 |
| Fischer Laurent | 762,462 | 0 |
| Flynn James E Through Deerfield Private Design Fund III, L.P. | 654,285 | 0 |
| Flynn James E Through Deerfield International Master Fund, L.P. | 627,267 | 0 |
| Blumenkranz Mark S. | 522,989 | 0 |
| Flynn James E Through Deerfield Partners, L.P. | 507,200 | 0 |
| Schwartz Steven Daniel | 367,931 | 0 |
| Soparkar Peter | 280,556 | 0 |
| Gasmi Mehdi | 274,442 | 0 |
| Chalberg Thomas W. | 258,988 | 0 |
| Flynn James E Through Deerfield Special Situations Fund, L.P. | 227,294 | 0 |
| Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | 181,633 | 0 |
| Clark Julie | 164,723 | 0 |
| PATTERSON LEONE D | 97,955 | 0 |
| Machado Patrick | 88,182 | 0 |
| Svoronos Dawn | 50,000 | 0 |
| Wachter Paul | 37,161 | 0 |
| D'Souza Rupert | 20,850 | 0 |
| Seyedkazemi Setareh | 20,600 | 0 |
| Hull Hans | 11,320 | 0 |
| Beckman Richard | 10,000 | 0 |
| Bain Linda | 9,000 | 0 |
| Scopa James Paul | 3,334 | 0 |
| Finer Mitchell H. | 0 | 0 |
| Versant Capital IV (Switzerland) GmbH Through Versant Side Fund IV, L.P. | 0 | 0 |
| Braun Shirley | 0 | 0 |
| Whitcup Scott M | 0 | 0 |
| Leung Thomas | 0 | 0 |
| Riley Brigit | 0 | 0 |
| Rubio Roman G. | 0 | 0 |
| Ozden Rabia Gurses | 0 | 0 |
| Woiwode Thomas | 0 | 0 |
| Thedinga Angela | 0 | 0 |
| Russo Carlo | 0 | 0 |
| Hong Soo | 0 | 0 |
| Barone Samuel B. | 0 | 0 |
| Osborne Aaron | 0 | 0 |
| Swartzburg Michael | 0 | 0 |
| Carter Eric G | 0 | 0 |
| THRIFT JACK ANTHONY | 0 | 0 |
| Versant Capital IV (Switzerland) GmbH Through Versant Capital IV (Switzerland) GmbH | 0 | 0 |
| Versant Capital IV (Switzerland) GmbH Through Versant Venture Capital IV, L.P. | 0 | 0 |
| Salzman Amber | 0 | 0 |
| Cleveland Paul B | 0 | 0 |
| Tuckson Reed Vaughn | 0 | 0 |
| MCLAUGHLIN JOHN PETER | 0 | 0 |
| Spivey Richard N. | 0 | 0 |
| PECOTA NANCY E | 0 | 0 |
| Hemrajani Rekha | 0 | 0 |
| Lupher, Jr. Mark L. | 0 | 0 |
| Rakow John | 0 | 0 |
| Cheng Jennifer C. | 0 | 0 |
| Countouriotis Athena | 0 | 0 |
| 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|